Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Tiantan Biological to Acquire Rongsheng Pharma

publication date: Dec 26, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Beijing Tiantan Biological Products Corporation Ltd., a biopharma company, will acquire a 90% interest in Chengdu Rongsheng Pharmaceutical Co., Ltd. for $84 million. Tiantan will use a combination of stock and cash to make the purchase. At the same time, the company said it will spend 1 billion RMB ($150 million) to build a modernized vaccine manufacturing facility in Daxing.  More details...

Stock Symbol: (SHSE: 600161)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners